Evaluation of risk factors for recurrent renal stone formation among Saudi Arabian patients: Comparison with first renal stone episode
https://doi.org/10.4081/aiua.2023.11361
Accepted: May 28, 2023
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Objectives: We evaluated the baseline characteristics, and risk factors of renal stone recurrence among Saudi Arabian patients after successful primary stone treatment. Materials and methods: In this cross-sectional comparative study, we reviewed the medical records of patients who presented consecutively with a first renal stone episode from 2015 to 2021 and were followed-up by mail questionnaire, telephone interviews, and/or outpatient clinic visit. We included patients who achieved stone-free status after primary treatment. Patients were divided into two groups: group I (patients with first episode renal stone) and group Ⅱ (patients who developed renal stone recurrence). The study outcomes were to compare the demographics of both groups and to evaluate the risk factors of renal stone recurrence after successful primary treatment. We used Student’s t-test, Mann Whitney test or chi-square (x2) to compare variables between groups. Cox regression analyses were used to examine the predictors. Results: We investigated 1260 participants (820 males and 440 females). Of this number, 877 (69.6%) didn’t develop renal stone recurrence and 383 (30.4%) had recurrence. Primary treatments were percutaneous nephrolithotomy (PCNL), retrograde intrarenal surgery (RIRS), extracorporeal shock wave lithotripsy (ESWL), surgery and medical treatment in 22.5%, 34.7%, 26.5%, 10.3%, and 6%, respectively. After primary treatment, 970 (77%) and 1011 (80.2%) of patients didn’t have either stone chemical analysis or metabolic work-up, respectively. Multivariate logistic regression analysis revealed that male gender (OR: 1.686; 95% CI, 1.216-2.337), hypertension (OR: 2.342; 95% CI, 1.439-3.812), primary hyperparathyroidism (OR: 2.806; 95% CI, 1.510-5.215), low fluid intake (OR: 28.398; 95% CI, 18.158-44.403) and high daily protein intake (OR: 10.058; 95% CI, 6.400-15.807) were predictors of renal stone recurrence. Conclusions: Male gender, hypertension, primary hyperparathyroidism, low fluid intake and high daily protein intake increase the risk of renal stone recurrence among Saudi Arabian patients.
Sorokin I, Mamoulakis C, Miyazawa K, et al. Epidemiology of stone disease across the world. World J Urol. 2017; 35:1301-1320. DOI: https://doi.org/10.1007/s00345-017-2008-6
Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010; 12: 86-96.
Zeng G, Mai Z, Xia S, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int. 2017; 120:109-116. DOI: https://doi.org/10.1111/bju.13828
Abdel-Halim RE, Al-Hadramy MS, Hussein M, et al. The prevalence of urolithiasis in the western region of Saudi Arabia: a population study. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG, editors. Urolithiasis. Boston, MA: Springer; p. 1989; 711-712. DOI: https://doi.org/10.1007/978-1-4899-0873-5_218
Ahmad F, Nada MO, Farid AB, et al. Epidemiology of urolithiasis with emphasis on ultrasound detection: a retrospective analysis of 5371 cases in Saudi Arabia. Saudi J Kidney Dis Transpl. 2015; 26:386-391. DOI: https://doi.org/10.4103/1319-2442.152557
Raja A, Hekmati Z, Joshi HB. How Do Urinary Calculi Influence Health-Related Quality of Life and Patient Treatment Preference: A Systematic Review. J Endourol. 2016; 30:727-43. DOI: https://doi.org/10.1089/end.2016.0110
Lotan Y. Economics and Cost of Care of Stone Disease. Advances in Chronic Kidney Disease. 2009; 16:5-10. DOI: https://doi.org/10.1053/j.ackd.2008.10.002
Trinchieri A, Ostini F, Nespoli R, et al. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol. 1999; 162:27-30. DOI: https://doi.org/10.1097/00005392-199907000-00007
Liu Y, Chen Y, Liao B, et al. Epidemiology of urolithiasis in Asia. Asian Journal of Urology. 2018; 5, 205-214. DOI: https://doi.org/10.1016/j.ajur.2018.08.007
Ho HC, Hughes T, Pietropaolo A, et al. Apnoea is not necessary for flexible ureteroscopy and lasertripsy of renal stones: A prospective study over 6 years. Cent European J Urol. 2020; 73:193-198. DOI: https://doi.org/10.1016/S2666-1683(20)33849-0
Matthew D’Costa, Vernon M. Pais, and Andrew D. Rule. Leave No Stone Unturned: Defining Recurrence in Kidney Stone Formers. Curr Opin Nephrol Hypertens. 2019; 28: 148-153. DOI: https://doi.org/10.1097/MNH.0000000000000478
Khalili P, Jamali Z, Sadeghi T, et al. Risk factors of kidney stone disease: a cross-sectional study in the southeast of Iran. BMC Urol. 2021; 21:141. DOI: https://doi.org/10.1186/s12894-021-00905-5
Dai M, Zhao A, Liu A, et al. Dietary Factors and Risk of Kidney Stone: A Case-Control Study in Southern China. J Ren Nutr. 2013;23:e21-8. DOI: https://doi.org/10.1053/j.jrn.2012.04.003
Ferraro PM, Bargagli M, Trinchieri A, et al. Risk of Kidney Stones: Influence of Dietary Factors, Dietary Patterns, and Vegetarian-Vegan Diets. Nutrients. 2020; 12:779. DOI: https://doi.org/10.3390/nu12030779
Vaughan LE, Enders FT, Lieske JC, et al. Predictors of symptomatic kidney stone recurrence after the first and subsequent episodes. Mayo Clin Proc. 2019; 94:202-10. DOI: https://doi.org/10.1016/j.mayocp.2018.09.016
Heller HJ, Sakhaee K, Moe OW, et al. Etiological role of estrogen status in renal stone formation. J Urol. 2002; 168:1923-7. 23. DOI: https://doi.org/10.1016/S0022-5347(05)64264-4
Liang L, Li L, Tian J, et al. Androgen receptor enhances kidney stone-CaOx crystal formation via modulation of oxalate biosynthesis & oxidative stress. Mol Endocrinol. 2014; 28:1291-303. DOI: https://doi.org/10.1210/me.2014-1047
Shang W, Li Y, Ren Y, et al. Nephrolithiasis and risk of hypertension: a meta-analysis of observational studies. BMC Nephrol. 2017; 18:1-6. DOI: https://doi.org/10.1186/s12882-017-0762-8
Kalani L, Rashidi N, Mehranfard S, et al. Epidemiology of the urinary stones: a 6-year retrospective study at Dezful-Iran. Int J Pharm Phytopharmacol Res. 2020; 10:79-85.
Wang K, Ge1 J, Han W, et al. Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis. BMC Urology. 2022; 22:62. DOI: https://doi.org/10.1186/s12894-022-01017-4
Liu F, Zhang N, Jiang P, et al. Characteristics of the urinary microbiome in kidney stone patients with hypertension. J Transl Med. 2020; 18:130. DOI: https://doi.org/10.1186/s12967-020-02282-3
Nasir SJ. The mineralogy and chemistry of urinary stones from the United Arab Emirates. Qatar Univ Sci J. 1999; 18:189-202.
Xu C, Zhang C, Wang XL, et al. Self-Fluid Management in Prevention of Kidney Stones: A PRISMA-Compliant Systematic Review and Dose-Response Meta-Analysis of Observational Studies. Medicine (Baltimore). 2015; 94:1042. DOI: https://doi.org/10.1097/MD.0000000000001042
Parks J, Coe F, Favus M. Hyperparathyroidism in nephrolithiasis. Arch Intern Med. 1980; 140:1479-81. DOI: https://doi.org/10.1001/archinte.140.11.1479
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
